Increased Expression of Yes-Associated Protein 1 in Hepatocellular Carcinoma with Stemness and Combined Hepatocellular-Cholangiocarcinoma

Relevant markers of cancer stem cells indicate a poor prognosis in hepatocellular carcinoma patients

(2013) Yu-Cheng Ma et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Overexpression of YAP and TAZ Is an Independent Predictor of Prognosis in Colorectal Cancer and Related to the Proliferation and Metastasis of Colon Cancer Cells

(2013) Lijuan Wang et al.   PLoS One

Combined Hepatocellular Carcinoma and Cholangiocarcinoma: Clinical Features, Treatment Modalities, and Prognosis

(2012) Xin Yin et al.   ANNALS OF SURGICAL ONCOLOGY

Combined hepatocellular-cholangiocarcinomas exhibit progenitor features and activation of Wnt and TGFβ signaling pathways

(2012) Cédric Coulouarn et al.   CARCINOGENESIS

An update on targeting Hippo-YAP signaling in liver cancer

(2012) Angela M Liu et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Clinicopathological analysis of 14 patients with combined hepatocellular carcinoma and cholangiocarcinoma

(2012) Xian-Huan Yu et al.   Hepatobiliary & Pancreatic Diseases International

Discrete nature of EpCAM+and CD90+cancer stem cells in human hepatocellular carcinoma

(2012) Taro Yamashita et al.   HEPATOLOGY

Transduction of mechanical and cytoskeletal cues by YAP and TAZ

(2012) Georg Halder et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Yes-Associated Protein 1 Exhibits Oncogenic Property in Gastric Cancer and Its Nuclear Accumulation Associates with Poor Prognosis

(2011) W. Kang et al.   CLINICAL CANCER RESEARCH

Human hepatocellular carcinomas with “Stemness”-related marker expression: keratin 19 expression and a poor prognosis

(2011) Haeryoung Kim et al.   HEPATOLOGY

Global Patterns of Cancer Incidence and Mortality Rates and Trends

(2010) A. Jemal et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer

(2010) Yang Wang et al.   CANCER SCIENCE

miR-130b Promotes CD133+ Liver Tumor-Initiating Cell Growth and Self-Renewal via Tumor Protein 53-Induced Nuclear Protein 1

(2010) Stephanie Ma et al.   Cell Stem Cell

Targeting YAP and Hippo signaling pathway in liver cancer

(2010) Angela M Liu et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation

(2010) I. Lian et al.   GENES & DEVELOPMENT

Role of p53 and β-catenin Mutations in Conjunction with CK19 Expression on Early Tumor Recurrence and Prognosis of Hepatocellular Carcinoma

(2010) Ray-Hwang Yuan et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Angiogenesis and clinicopathologic characteristics in different hepatocellular carcinoma subtypes defined by EpCAM and α-fetoprotein expression status

(2010) Yun-feng Shan et al.   MEDICAL ONCOLOGY

The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis

(2010) K.-P. Lee et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma

(2009) Michelle Z. Xu et al.   CANCER

Regulation of organ size: Insights from theDrosophilaHippo signaling pathway

(2009) Madhuri Kango-Singh et al.   DEVELOPMENTAL DYNAMICS

Significance of CD90+ Cancer Stem Cells in Human Liver Cancer

(2008) Zhen Fan Yang et al.   CANCER CELL

The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells

(2008) Sendurai A. Mani et al.   CELL

Ezrin expression is associated with hepatocellular carcinoma possibly derived from progenitor cells and early recurrence after surgical resection

(2008) Daiki Okamura et al.   MODERN PATHOLOGY